The quarterly territory review is one of the most consistent rituals in medical device commercial operations. Every 90 days, a regional director or sales manager pulls together what they know about their territory — who is performing, where the opportunity is, what the gap to plan looks like — and presents it to leadership. Then everyone agrees on what to do, and the team executes until the next review.

The problem is not that the ritual is wrong. The problem is that the inputs are usually wrong. By the time a quarterly review is being prepared, the data feeding it is already 30 to 60 days old. Market shifts that happened in the first six weeks of the quarter are only showing up now. Accounts that were prioritised in January may have already changed profile by March.

30–60
Days of data lag
Typical age of data feeding a quarterly review by the time it is presented to leadership
94%
Forecast accuracy
Achievable with daily-retraining AI models vs. a manual baseline of roughly 70–75%
80%
Less prep time
Reduction in time spent preparing each forecast cycle when the model updates automatically
Daily
Data refresh
How often a modern commercial intelligence model retrains — not monthly or quarterly

The Quarterly Review Was Designed for a Different Data Environment

When quarterly reviews became standard practice, pulling fresh territory data took days. The effort of compiling it justified doing it once every three months. That constraint no longer exists — but the cadence stayed, and most teams are still running their commercial operations on a model built around an infrastructure limitation that was solved years ago.

The result is a structural lag between what is happening in a territory and when leadership finds out about it. For a medical device company operating in a market where procedure volumes, physician referral patterns, and competitive dynamics all move faster than a 90-day reporting cycle, that lag is expensive.

“A territory review built on 60-day-old data is not a review of the territory. It is a review of what the territory used to look like.”

What a Current Territory Review Looks Like

A territory review built on current data looks structurally different. Instead of opening with a reconciliation of what happened versus what was planned, it opens with a live ranked view of where opportunity sits today — by account, by physician, by product line — and the conversation starts with what to do about it.

Accounts that have shifted since the last review show up as movement, not surprises. A physician whose procedure volume has been climbing for six weeks is already flagged. A territory that is pacing ahead of plan can have its quota targets revisited before the quarter closes, not after.

The Meeting That Changes

The practical effect shows up most clearly in what the meeting itself becomes. A territory review built on current data is shorter, because the team is not spending the first half reconciling the numbers. It is more decisive, because the next action is already visible in the data. And it leaves the room with fewer open questions, because the analysis did not depend on anyone’s memory of what happened last month.

That is a meaningful change for a team that runs these reviews across 10 or 20 territories every quarter. The time savings compound. The decisions improve. And the lag between what is happening in the market and what leadership knows about it shrinks from weeks to hours.

Sources

  1. Trapezoid Solutions — internal reported figures, forecast accuracy and cycle time benchmarks
  2. Salesforce — “40 Sales Statistics to Watch for in 2026,” State of Sales report